Employers and insurance companies must submit details on prescription drugs and health care spending through the RxDC report. Below are tools and resources to help with your submission.
Reporting Instructions
Reporting Instructions
Prescription Drug Data Collection (RxDC) Reporting Instructions: Section 204 Data Submission Instructions
2022 Reporting Instructions
Retired Prescription Drug Data Collection (RxDC) Reporting Instructions: Section 204 Data Submission Instructions for the 2022 Reference Year
2020 and 2021 Reporting Instructions
Prescription Drug Data Collection (RxDC) Reporting Instructions: Section 204 Data Submission Instructions for the Reference Years 2020 and 2021
More resources
2024 Report to Congress
Prescription Drug Spending, Pricing Trends, and Premiums in Private Health Insurance Plans.
2024 Appendix
Prescription Drug Prices, Rebates, and Insurance Premiums.
RxDC FAQs - Updated May 2023
Frequently Asked Questions (FAQs) for Prescription Drug Data Collection (RxDC).
RxDC FAQs - December 2022
Frequently Asked Questions (FAQs) for Prescription Drug Data Collection (RxDC).
Affordable Care Act Implementation FAQs Part 56
Frequently Asked Question (FAQ) regarding implementation of certain provisions of Title II (Transparency) of Division BB of the Consolidated Appropriations Act, 2021 (CAA).
CMS Fact Sheet: Prescription Drug and Health Care Spending Interim Final Rule with Request for Comments
On November 17, 2021, the Department of Health and Human Services (HHS), together with the Department of Labor (DOL) and the Department of the Treasury (collectively, the Departments), as well as the Office of Personnel Management (OPM), released an interim final rule with request for comments (IFC), entitled “Prescription Drug and Health Care Spending.
RxDC templates and data dictionary
Try these free templates when submitting your 2023 RxDC report.
RxDC drug name and therapeutic class crosswalk
Download this document to compare drug names and therapeutic classes.